United States · Who invested in Bioniz Therapeutics?
Bioniz Therapeutics's investors include Takeda Ventures and David Pyott & Takeda Ventures. Takeda Ventures led its latest round.
United States · Series A startup
Who invested in Bioniz Therapeutics
Funding summaryUpdated 26 Oct 2026
$13Mraised across 1 round since 2016, from 1 source
- Latest round
- Series A, $13MAug 2016
- Led by
- Takeda Ventures
- Investors
- 2 (1 led)
The rounds
- Aug 2016Series A$13M
- Takeda VenturesLead
- David Pyott & Takeda Ventures
Reported by SocaltechSEC filing: $11M sold, first sale Dec 2015
Founders and team
From the SEC filings it signed: 3 on the team.
- Fredrik E.I. WiklundExecutive Officeri
- Nazli AzimiExecutive Officer, Directori
- Paul E.I. FrohnaExecutive Officeri
On the board, as filediDavid E.I. PyottGraham E.I. CooperJoe KianiMichael E.I. Martin
Quick answers about Bioniz Therapeutics
How much has Bioniz Therapeutics raised?
Bioniz Therapeutics has raised $13M across 1 round since 2016.
When did Bioniz Therapeutics last raise?
Bioniz Therapeutics's most recent round was a Series A of $13M in Aug 2016, led by Takeda Ventures.
What was Bioniz Therapeutics's biggest round?
Its most recent round, $13M in Aug 2016, is also its largest on record.
Who backed Bioniz Therapeutics first?
Bioniz Therapeutics's first round on record, in Aug 2016, was backed by Takeda Ventures and David Pyott & Takeda Ventures.
What stage is Bioniz Therapeutics at?
Bioniz Therapeutics's latest named round is a Series A, in Aug 2016.
Where is Bioniz Therapeutics based?
Bioniz Therapeutics is based in the United States.
Who led Bioniz Therapeutics's rounds?
Takeda Ventures led the Series A in 2016.
Companies like Bioniz Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.